LICENSE AND OPTION AGREEMENTLicense Agreement • February 14th, 2003 • Valentis Inc • Biological products, (no disgnostic substances) • New York
THIS LICENSE AND OPTION AGREEMENT (“Agreement”) effective as of December 19, 2002 (“Effective Date”), is made and entered into by and between VALENTIS, INC., a Delaware corporation, having its principal place of business at 863A Mitten Road, Burlingame, CA 94010, USA (“Valentis”) and SCHERING AG, a German corporation having its principal place of business at Müllerstrasse 178, 13353 Berlin, Germany (“Schering”). Valentis and Schering each may be referred to herein individually as a “Party,” or collectively as the “Parties.”
